Correlation Between Jinhe Biotechnology and Markor International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Markor International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Markor International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and Markor International Home, you can compare the effects of market volatilities on Jinhe Biotechnology and Markor International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Markor International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Markor International.

Diversification Opportunities for Jinhe Biotechnology and Markor International

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Jinhe and Markor is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Markor International Home in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Markor International Home and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Markor International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Markor International Home has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Markor International go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Markor International

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to generate 0.64 times more return on investment than Markor International. However, Jinhe Biotechnology Co is 1.56 times less risky than Markor International. It trades about 0.19 of its potential returns per unit of risk. Markor International Home is currently generating about 0.1 per unit of risk. If you would invest  428.00  in Jinhe Biotechnology Co on September 2, 2024 and sell it today you would earn a total of  31.00  from holding Jinhe Biotechnology Co or generate 7.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  Markor International Home

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Markor International Home 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Markor International Home are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Markor International sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology and Markor International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and Markor International

The main advantage of trading using opposite Jinhe Biotechnology and Markor International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Markor International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Markor International will offset losses from the drop in Markor International's long position.
The idea behind Jinhe Biotechnology Co and Markor International Home pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance